
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares
ETF
Equity
- years
8 holdings
$11.27
Price+0.81%
$0.09
$2.368m
Small
$13.369k
Avg Volume$3.353m
$15.02
NAV0.95%
Expense Ratio5.32%
Yield$0.60
Dividend